Alpitour’s Journey to RPA Success | UiPath
See how Alpitour’s adoption of UiPath’s Robotic Process Automation has improved efficiency, productivity, and employee satisfaction.
Related Articles
What’s Behind the Remarkable Drop in U.S. Overdose Deaths (Gift Article)
Experts are puzzling over which interventions are saving lives. The evolving illicit supply itself may hold important clues.
Amid cost debate, new study finds 137M US adults are eligible for GLP-1s
Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American adults would benefit from the…
Measles outbreak: Almost 30 per cent of N.B. kindergartners not fully vaccinated
Almost 30 per cent of students starting kindergarten in New Brunswick public schools last year did not meet vaccination rules.
Health Leaders Applaud Biden’s Proposal to Expand Medicare/Medicaid Coverage for Anti-Obesity Medications – MedCity News
Several healthcare leaders are supporting the Biden-Harris administration’s proposed rule to expand Medicare and Medicaid coverage of GLP-1 medications for obesity treatment.
‘Mind boggling’ surge in pneumonia cases among children, teens and young adults
Area doctors and hospitals are seeing a ‘stunning surge’ in walking pneumonia cases, something being seen around the globe this year.
Vanessa Kerry is on a mission to make the health care system resilient to climate change
Climate change is exacerbating health disparities around the world, says Seed Global Health founder Vanessa Kerry
Some ID Things to Be Grateful for This Holiday Season — 2024 Edition
The calendar says it’s nearly the fourth Thursday of November, so here in the United States, the Thanksgiving holiday is upon us. It’s a day…
Sign Up for Health Essentials | Cleveland Clinic
Looking for health & wellness tips? Get fitness, health and wellness tips sent to you weekly. Sign up for our Health Essentials newsletter today!
Signify Heath is expanding its offerings and making more visits. Here’s how
LAS VEGAS — CVS’ home health arm Signify Health is set to make 3.3 million home visits this year, and the team isn’t looking to…
Roche to buy cell therapy developer Poseida for $1B
The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing share price on Monday.
